Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Submitted by
admin
on October 18, 2013 - 5:47pm
Source:
Bloomberg
News Tags:
Actelion
FDA
Opsumit
PAH
Headline:
Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Do Not Allow Advertisers to Use My Personal information
